Filter :
Standard and/or project under the direct responsibility of ISO/TC 276/SC 1 Secretariat Stage ICS
Biotechnology — Inventory of methods for detection of microbiological contamination in mammalian cell culture
60.60
Biotechnology — Genome editing — Part 1: Vocabulary
90.92
Biotechnology — Genome editing — Part 1: Vocabulary — Amendment 1
60.60
ISO/AWI 5058-1 [Under development]
Biotechnology — Genome editing — Part 1: Vocabulary
20.00
Biotechnology — Cell viability analytical methods — Part 1: General requirements and considerations
60.60
ISO/CD 8934-2 [Under development]
Biotechnology --Cell viability analytical methods — Part 2: Experimental Designs and Statistical Analysis for Evaluating the Quality of Cell Count-Based Viability Methods
30.60
ISO/WD 12833 [Under development]
Biotechnology — Requirements for RNA quantification methods for gene expression analysis of biological and bioengineered systems
20.60
Biotechnology — Gene delivery systems — Part 1: Vocabulary
60.60
Biotechnology — Gene delivery systems — Part 2: Quantification methods for viral vectors
60.60
ISO/WD 16921-3 [Under development]
Biotechnology — Gene delivery systems — Part 3: Guide for Methods for the Quantification and Characterization of Lipid Nanoparticles
20.60
Biotechnology — Cell counting — Part 1: General guidance on cell counting methods
90.92
ISO 20391-1 [Under development]
Biotechnology — Cell counting — Part 1: General requirements and recommendations for cell counting analytical methods
60.00
Biotechnology — Cell counting — Part 2: Experimental design and statistical analysis to quantify counting method performance
90.93
Biotechnology — Requirements for evaluating the performance of quantification methods for nucleic acid target sequences — qPCR and dPCR
90.92
ISO/CD 20395 [Under development]
Biotechnology — Requirements for evaluating the performance of quantification methods for nucleic acid target sequences — qPCR and dPCR
30.60
Biotechnology — Massively parallel sequencing — Part 1: Nucleic acid and library preparation
90.92
ISO/AWI 20397-1 [Under development]
Biotechnology — NGS — Part 1: Nucleic acid and library preparation
10.99
Biotechnology — Massively parallel sequencing — Part 2: Quality evaluation of sequencing data
90.92
ISO/AWI 20397-2 [Under development]
Biotechnology — NGS — Part 2: Quality evaluation of sequencing data
10.99
Biotechnology — Massively parallel sequencing — Part 3: General requirements and guidance for metagenomics
90.92
ISO/AWI 20397-3 [Under development]
Biotechnology — NGS — Part 3: General requirements and guidance for metagenomics
10.99
Biotechnology — Nucleic acid synthesis — Part 1: Requirements for the production and quality control of synthesized oligonucleotides
90.93
Biotechnology — Nucleic acid synthesis — Part 2: Requirements for the production and quality control of synthesized gene fragments, genes, and genomes
60.60
ISO/TS 21085 [Under development]
Biotechnology — General requirements for the measurement of ultra-low concentration samples of target nucleic acid sequence
60.00
ISO/AWI 23033-1 [Under development]
Biotechnology – Cell characterization — Part 1: General requirements and considerations for the testing and characterization of cellular therapeutic products
10.99
Biotechnology — Analytical methods — General requirements and considerations for the testing and characterization of cellular therapeutic products
90.92
ISO 23511 [Under development]
Biotechnology — General requirements and considerations for cell line identification and cross-contamination testing
60.00
Biotechnology — Analytical methods — Risk-based approach for method selection and validation for rapid microbial detection in bioprocesses
60.60
Biotechnology — Minimum requirements for optical signal measurements in photometric methods for biological samples
60.60
Biotechnology — Cellular morphological analysis — General requirements and considerations for cell morphometry to quantify cell morphological features
60.60
ISO/AWI 25824 [Under development]
General requirements and considerations for cell-mediated cytotoxicity assays used in characterization and testing of CAR products for therapeutic use
20.00
ISO/AWI 26012 [Under development]
General Requirements and Considerations for AAV Capsid Content Characterization for Gene Therapy
20.00
ISO/WD 26125-1 [Under development]
Biotechnology — Tumorigenicity testing — Part 1: General requirements and considerations for testing of cellular therapeutic products
20.60

No matching records found. Please try changing the filter settings.